Novartis AG Common Stock (NVS)
Total Costs & Expenses
$9.68B
Quarterly · Period ending: · USD
NVS Total Costs & Expenses
Latest reported$9.68Bperiod ending
Latest reported$9.68Bperiod ending
NVS Quarterly Total Costs & Expenses ($5.70B → $9.68B)
Quarterly Total Costs & Expenses
High-resolution chart · PNG
NVS total costs & expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Costs & Expenses (USD) |
|---|---|
| 3,341,000,000 | |
| 4,440,000,000 | |
| 5,961,000,000 | |
| 4,881,000,000 | |
| 3,278,000,000 | |
| 5,697,000,000 |